Benefits Agency

News and Video Search Results

News coverage

Applied Systems and Bravo Networks Expand Partnership to Support Client Money Management in Applied Epic

GlobeNewswire 07 May 2024

Bravo Networks to support Applied Epic brokers in handling client money for greater time and cost savings

Brighton, UK,..

Infinity Bancorp Announces First Quarter 2024 Financial Results
Accesswire 07 May 2024
Quaint Oak Bancorp, Inc. Announces First Quarter Earnings
GlobeNewswire 06 May 2024
Alto Ingredients, Inc. Reports First Quarter 2024 Results
GlobeNewswire 06 May 2024
South Star Battery Metals Announces the First Sale of Natural Flake Graphite Concentrate from its Santa Cruz Graphite Mine in Brazil
Accesswire 06 May 2024

0 shares 1 views

You might like

Benefits Agency media coverage

Meet One of the "Biggest Airdrops", UXLINK Airdrop Voucher NFT Launched

GlobeNewswire 06 May 2024

Singapore , May 06, 2024 (GLOBE NEWSWIRE) --UXLINK, the "Social Monster", has issued the "IN UXLINK WE TRUST '' series of NFTs as..

Safety Shot Provides Shareholder Update Highlighting Significant Milestones and Progress
GlobeNewswire 06 May 2024
CipherDriveOne Kryptr Achieves Common Criteria Certification
Accesswire 06 May 2024
Germany Travel Insurance Market is Poised to Travel Fast at a Robust CAGR of 29.4% and Reach Euro 623.9 Million By 2032: Astute Analytica
GlobeNewswire 06 May 2024
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 06 May 2024

Advertisement

More coverage

USI Insurance Services Acquires Hignojos Insurance Agency

GlobeNewswire 06 May 2024

New Partnership Expands USI’s Texas-Based Presence and Expertise

VALHALLA, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- USI..

FWD Max Wealth offers protection and maximises rewards for milestones in life
PR Newswire Asia 06 May 2024
TAR-210 results show 90 percent recurrence-free survival and 90 percent complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively
GlobeNewswire 05 May 2024
Phase 2 data for ERLEADA® ▼(apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer shows 100 percent biochemical free recurrence rate more than two years post-surgery
GlobeNewswire 03 May 2024
Arbor Realty Trust Reports First Quarter 2024 Results and Declares Dividend of $0.43 per Share
GlobeNewswire 03 May 2024